Trials / Terminated
TerminatedNCT01384695
A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1
A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia - Project 1
- Status
- Terminated
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 67 (actual)
- Sponsor
- Anandasabapathy, Sharmila, M.D. · Individual
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of the gastrointestinal mucosain vivo can assist clinicians in detecting dysplastic (precancerous) areas. This is an exploratory study of a confocal endoscope designed to evaluate the feasibility of using this FDA-approved device in the endoscopic surveillance of subjects at high-risk for neoplasia in the upper and lower GI tract. The confocal endoscope provides real-time in vivo microscopic images of the mucosa which resemble standard pathology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluorescein | fluorescent contrast agent, Fluorescein 5ml |
| DRUG | Proflavine hemisulfate | 3 ml of 0.01% proflavine (derived from dissolving 10mg proflavine hemisulfate USP in 100ml sterile water) |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2011-06-29
- Last updated
- 2016-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01384695. Inclusion in this directory is not an endorsement.